Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal biologic trough concentration to maintain stable psoriasis
2012-005809-53Phase 4Active
- Start
- Feb 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab, etanercept, ustekinumab in psoriasis. Started Feb 2013; status: active.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2012-005809-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005809-53.